| Course | DNRS 6521 Advanced Pharmacology (DNP level) |
|---|---|
| Week | Week 7 |
| Paper type | Medication monitoring plan |
| Length | About 570 words, 5 pages |
| Format | APA 7 student paper |
| School | Walden University |
| Program | Doctor of Nursing Practice (DNP) |
| Updated | October 2026 |
Free sample paper for DNRS 6521 Week 7
Monitoring Plan: Four Parameters for a 67-Year-Old Man Starting Amiodarone for Atrial Fibrillation
Student Name
College of Nursing, Walden University
DNRS 6521: Advanced Pharmacology (DNP level)
Instructor Name
Month Day, Year
Monitoring Plan: Four Parameters for a 67-Year-Old Man Starting Amiodarone for Atrial Fibrillation
Why These Four
A composite 67-year-old man with persistent atrial fibrillation and heart failure with reduced ejection fraction is starting amiodarone for rhythm control, a use supported where other antiarrhythmics are unsuitable in heart failure (Joglar et al., 2024). His liver carries fat from metabolic disease, with mildly raised enzymes a year ago, and he takes apixaban, which does not need INR monitoring.
Amiodarone can affect almost every organ, and a list of eight or more parameters is easy to write. This plan chooses four because they cover the effects that are either common or dangerous and that a test can detect before the patient is harmed. Even at low doses, amiodarone raised the odds of thyroid, neurologic, skin, ocular, and bradycardic adverse effects compared with placebo, with a trend toward more pulmonary toxicity (Vorperian et al., 1997). Thyroid dysfunction and bradycardia are common and detectable by routine tests; amiodarone's large iodine content and direct effects on the gland can cause either hypothyroidism or thyrotoxicosis, so a single thyroid test at baseline is not enough (Martino et al., 2001). Pulmonary toxicity is less common but the most likely to be fatal, so it earns a place. Liver injury was not more frequent than placebo at low doses in that meta-analysis, but it stays in this plan because he already has fatty liver disease and the practical guide for amiodarone recommends liver tests at baseline and during therapy (Goldschlager et al., 2007). Eye and skin effects are followed by symptoms and counseling rather than scheduled tests, because routine testing would rarely change management.
The Plan
Table 1
Amiodarone Monitoring Plan
| Parameter | Expected to detect | Interval | Change that prompts action | Source for interval |
|---|---|---|---|---|
| TSH, with free T4 if abnormal | Amiodarone-induced hypothyroidism or thyrotoxicosis | Baseline, then every 6 months | TSH outside the reference range, or new symptoms of thyroid dysfunction | Goldschlager et al., 2007; Martino et al., 2001 |
| ALT and AST | Hepatocellular injury | Baseline, then every 6 months | Aminotransferases above twice the upper limit of normal: review dose and consider stopping | Goldschlager et al., 2007 |
| 12-lead ECG | Bradycardia, AV block, QT prolongation | Baseline, after loading, then yearly | Symptomatic bradycardia, new AV block, or QTc above 500 ms | Zimetbaum, 2007 |
| Chest radiograph and pulmonary function with diffusing capacity | Pulmonary toxicity | Baseline; then chest radiograph yearly and full testing if symptoms develop | New cough, breathlessness, or infiltrate: stop and investigate | Goldschlager et al., 2007 |
Patient-Reported Information
The plan depends on what he notices between tests, especially for the lungs, where symptoms usually come before a scheduled radiograph would. At each visit and by phone between visits, he answers five questions: new or worse cough, breathlessness beyond his usual, lightheadedness or fainting, unexplained weight change or heat or cold intolerance, and blurred vision or halos around lights. Answers are recorded in a flowsheet so they can be compared over time. He and his wife have been told that any new cough or breathlessness is a reason to call the same week, not to wait for the next visit.
When the Plan Itself Changes
The plan is revised if the dose changes, if a new drug that prolongs the QT interval or interacts with amiodarone is added, or if amiodarone is stopped. Because amiodarone's elimination half-life is measured in weeks, thyroid and pulmonary monitoring continues for several months after the last dose rather than ending with it (Zimetbaum, 2007).
References
Goldschlager, N., Epstein, A. E., Naccarelli, G. V., Olshansky, B., Singh, B., Collard, H. R., & Murphy, E. (2007). A practical guide for clinicians who treat patients with amiodarone: 2007. Heart Rhythm, 4(9), 1250-1259. https://doi.org/10.1016/j.hrthm.2007.07.020
Joglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., Gorenek, B., Hess, P. L., Hlatky, M., Hogan, G., Ibeh, C., Indik, J. H., Kido, K., Kusumoto, F., Link, M. S., . . . Van Wagoner, D. R. (2024). 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 149(1), e1-e156. https://doi.org/10.1161/CIR.0000000000001193
Martino, E., Bartalena, L., Bogazzi, F., & Braverman, L. E. (2001). The effects of amiodarone on the thyroid. Endocrine Reviews, 22(2), 240-254. https://doi.org/10.1210/edrv.22.2.0427
Vorperian, V. R., Havighurst, T. C., Miller, S., & January, C. T. (1997). Adverse effects of low dose amiodarone: A meta-analysis. Journal of the American College of Cardiology, 30(3), 791-798. https://doi.org/10.1016/S0735-1097(97)00220-9
Zimetbaum, P. (2007). Amiodarone for atrial fibrillation. The New England Journal of Medicine, 356(9), 935-941. https://doi.org/10.1056/NEJMct065916
DNRS 6521 Week 7 instructions, in plain terms
The seventh week often asks for a monitoring plan for a high-risk medication in a specific patient. You select the parameters to follow, justify each one, set baseline and follow-up intervals, and state what result would prompt action. Prompts frequently stress that the plan should be practical for a real clinic, so fewer well-chosen parameters may score better than many. Expect a short paper or structured document in APA 7, often with a table. Patient education or self-reported symptoms are commonly part of the plan. Some sections ask how the plan would change with a dose change, a new drug or a worrying result. Cite guidelines for the intervals you choose and name any intervals that rest on expert opinion rather than trials.
Inside the DNRS 6521 Week 7 example
A two-page document with a short narrative and a table that actually earns its place. Four parameters appear, and each row carries five things: the parameter, what it is expected to detect, the interval, the change that would prompt action, and the source supporting that interval. The narrative above the table explains why these four and not the eight a longer list would have offered, which is the paragraph that separates a plan from an inventory. A second short paragraph handles the patient-reported information the plan depends on and how it will be captured. The close states the point at which the plan itself would be revised. Five references, several of them attached to the intervals rather than to the parameters.
Reading the DNRS 6521 Week 7 rubric
Plans are marked on defensibility rather than on completeness, which reverses the instinct most writers bring to them. A document listing eight parameters with no reason for any of them scores below one carrying four with reasons attached. The interval column is where credit is quietly lost, because intervals stated without support look invented and frequently are. Graders read the action thresholds for specificity, since a threshold phrased as any significant change gives a colleague nothing to act on. Patient-reported information is often missing entirely, and its absence is noticed in a doctoral rubric that asks for a whole plan. Formatting counts more than usual here, as the assignment is producing a working document rather than a paper, and an unreadable table costs points a reader can see immediately.
DNRS 6521 Week 7 help: mistakes that cost marks
Monitoring plans lose credit when they list every test in the labeling without saying why each one matters for this patient. Choose the parameters and defend them. Another mistake is giving intervals with no thresholds, so the plan never says what result would change anything. Students also forget the baseline, though without one later results cannot be read. Keep the patient in the plan by naming the symptoms he should report and how. Avoid citing intervals to a source that does not give them; say when an interval comes from expert consensus. Read the table against the text line by line. Finally, include a section on when the plan itself should be revised, such as after a dose reduction.
Get a DNRS 6521 Week 7 example written to your instructions
Send the plan prompt, the case, and whether a table or narrative format is required, and a plan with reasons, intervals and thresholds attached comes back to you. The first custom one is free and lands inside 24 to 48 hours. Monitoring data on a person in your care stays in their chart.
More DNRS 6521 papers and DNP samples
- DNRS 6521 Week 1: Discussion Post
- DNRS 6521 Week 2: Case Write-Up
- DNRS 6521 Week 3: Pharmacogenomic Memo
- DNRS 6521 Week 4: Decision Case
- DNRS 6521 Week 5: Discussion Post
- DNRS 6521 Week 6: Interaction Analysis
- DNRS 6521 Week 8: Prescribing Ethics Case
- DNRS 6521 Week 9: Formulary Review
- DNRS 6521 Week 10: Deprescribing Plan
- DNRS 6521 Week 11: QI Proposal
- NURS 6001 Week 7: Weekly study time budget
- DNRS 6501 Week 7: Differential Analysis
- NURS 6002 Week 7: Scholarly register rewrite
- NURS 6914 Week 7: Case analysis
DNRS 6521 Week 7 questions, answered
How many parameters should a plan carry?
Four defended parameters generally outscore ten listed, unless the prompt sets a number. The scored quality is selection, and every parameter added without a reason dilutes the ones that had one. Where a rubric names required categories, those come first and the writer's own additions each need the same reason, interval and threshold attached.
Where do the intervals come from?
Published guidance, primary studies and the handling properties of the agent, cited in the table rather than asserted. This is the part of a monitoring plan graders check most closely, because invented intervals are common and easy to spot. The example attaches a source to each timing claim and says where guidance is silent.
Does the plan need a table?
Only if the prompt asks for one, though the format suits the content. What matters is that detection, interval and threshold stay visibly linked, which prose can do if the paragraphs are disciplined. If your classroom supplies a template, that template governs, and the reasoning paragraph above it remains the part carrying the credit.
Where can I find a free DNRS 6521 Week 7 sample paper?
The amiodarone monitoring plan is reproduced here in full with its four parameters, the table of intervals and thresholds, and margin notes on each choice.
What should be monitored on amiodarone in DNRS 6521 Week 7?
The example follows thyroid function, liver enzymes, lung symptoms with baseline imaging, and the ECG, each with a baseline, a repeat interval and a threshold for action.